✦ LIBER ✦

Erkitinib, a novel EGFR tyrosine kinase inhibitor screened using a ProteoChip system from a phytochemical library

✍ Scribed by Eung-Yoon Kim; Young-Jin Choi; Chan-Won Park; In-Cheol Kang

Book ID: 116299149
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 586 KB
Volume: 389
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2009.08.141

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of Novel Bruton’s Tyrosine Kin

Discovery of Novel Bruton’s Tyrosine Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approaches Based on SVM Model, Pharmacophore and Molecular Docking

✍ Hua-Lin Wan; Ze-Rong Wang; Lin-Li Li; Chuan Cheng; Pan Ji; Jing-Jing Liu; Hui Zh 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Discovery of Novel Bruton’s Tyrosine Kin

Discovery of Novel Bruton’s Tyrosine Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approaches Based on SVM Model, Pharmacophore and Molecular Docking

✍ Hua-Lin Wan; Ze-Rong Wang; Lin-Li Li; Chuan Cheng; Pan Ji; Jing-Jing Liu; Hui Zh 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Bruton’s tyrosine kinase has emerged as a potential target for the treatment for B‐cell malignancies and autoimmune diseases. Discovery of Bruton’s tyrosine kinase inhibitors has thus attracted much attention recently. In this investigation, we introduced a hybrid protocol of virtual screening metho

ZD1839, a novel, oral epidermal growth f

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program

✍ Pallis, A.G.; Mavroudis, D.; Androulakis, N.; Souglakos, J.; Kouroussis, C.; Boz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 195 KB